Rise Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $357 | Buy |
9
+7
| +350% | +$278 | ﹤0.01% | 1461 |
|
|
2025
Q1 | $92 | Sell |
2
-585
| -100% | -$26.9K | ﹤0.01% | 1459 |
|
|
2024
Q4 | $19.8K | Buy |
587
+6
| +1% | +$203 | 0.01% | 666 |
|
|
2024
Q3 | $23.8K | Buy |
581
+5
| +0.9% | +$204 | 0.01% | 567 |
|
|
2024
Q2 | $22.2K | Buy |
576
+6
| +1% | +$231 | 0.01% | 567 |
|
|
2024
Q1 | $24.4K | Buy |
+570
| New | +$24.4K | 0.01% | 508 |
|
|
2023
Q2 | – | Sell |
-41
| Closed | -$1.45K | – | 725 |
|
|
2023
Q1 | $1.45K | Buy |
41
+1
| +3% | +$35 | ﹤0.01% | 609 |
|
|
2022
Q4 | $1.42K | Hold |
40
| – | – | ﹤0.01% | 612 |
|
|
2022
Q3 | $1K | Sell |
40
-1
| -2% | -$25 | ﹤0.01% | 629 |
|
|
2022
Q2 | $2K | Buy |
41
+1
| +3% | +$49 | ﹤0.01% | 553 |
|
|
2022
Q1 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 532 |
|